[27PO1-am2] In-house formulation/Management of intravenous and enteral nutrition/Drug management/Therapeutic drug monitoring (TDM) and administration plans

[27PO1-am2-78] Relationship among 6-mercaptopurine dose, metabolites and clinical laboratory test on maintenance therapy for children with acute lymphoblastic leukemia

○Yoichi Tanaka¹, Rintaro Ono², Miho Ashiarai², Ayako Sakurai³, Atsushi Watanabe⁴, Daisuke Hasegawa², Yoshiro Saito¹ (1. Division of Medicinal Safety Science, National Institute of Health Sciences, 2. Department of Pediatrics, St. Luke's International Hospital, 3. Department of Pediatrics, Japanese Red Cross Narita Hospital, 4. Department of Pediatrics, University of Yamanashi)